| Nonmotor fluctuations in Parkinson’s disease Frequent and disabling T Witjas, E Kaphan, JP Azulay, O Blin, M Ceccaldi, J Pouget, M Poncet, ... Neurology 59 (3), 408-413, 2002 | 851 | 2002 |
| Postural deformities in Parkinson's disease KM Doherty, BP van de Warrenburg, MC Peralta, L Silveira-Moriyama, ... The Lancet Neurology 10 (6), 538-549, 2011 | 561 | 2011 |
| Visual control of locomotion in Parkinson's disease JP Azulay, S Mesure, B Amblard, O Blin, I Sangla, J Pouget Brain 122 (1), 111-120, 1999 | 457 | 1999 |
| Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti‐GM1 antibodies: a double‐blind, placebo‐controlled study JP Azulay, O Blin, J Pouget, J Boucraut, F Bille-Turc, G Carles, ... Neurology 44 (3 Part 1), 429-429, 1994 | 321 | 1994 |
| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 286 | 2017 |
| Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation T Witjas, C Baunez, JM Henry, M Delfini, J Regis, AA Cherif, JC Peragut, ... Movement disorders: official journal of the Movement Disorder Society 20 (8 …, 2005 | 261 | 2005 |
| Postural disorders in Parkinson’s disease I Benatru, M Vaugoyeau, JP Azulay Neurophysiologie Clinique/Clinical Neurophysiology 38 (6), 459-465, 2008 | 239 | 2008 |
| Impaired vertical postural control and proprioceptive integration deficits in Parkinson’s disease M Vaugoyeau, S Viel, C Assaiante, B Amblard, JP Azulay Neuroscience 146 (2), 852-863, 2007 | 223 | 2007 |
| Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo … C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ... The Lancet Neurology 11 (7), 589-596, 2012 | 215 | 2012 |
| MUSK, a new target for mutations causing congenital myasthenic syndrome F Chevessier, B Faraut, A Ravel-Chapuis, P Richard, K Gaudon, ... NEUROMUSCULAR DISORDERS 15 (9-10), 736-736, 2005 | 205 | 2005 |
| MUSK, a new target for mutations causing congenital myasthenic syndrome F Chevessier, B Faraut, A Ravel-Chapuis, P Richard, K Gaudon, ... Human molecular genetics 13 (24), 3229-3240, 2004 | 205 | 2004 |
| Influence of visual cues on gait in Parkinson's disease: contribution to attention or sensory dependence? JP Azulay, S Mesure, O Blin Journal of the neurological sciences 248 (1-2), 192-195, 2006 | 203 | 2006 |
| Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy O Blin, C Desnuelle, O Rascol, M Borg, HP Saint Paul, JP Azulay, F Bille, ... Journal of the neurological sciences 125 (1), 95-101, 1994 | 191 | 1994 |
| Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease T Witjas, E Kaphan, J Régis, E Jouve, AA Chérif, JC Péragut, JP Azulay Movement disorders: official journal of the Movement Disorder Society 22 (12 …, 2007 | 190 | 2007 |
| Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial D Devos, C Moreau, D Maltête, R Lefaucheur, A Kreisler, A Eusebio, ... J Neurol Neurosurg Psychiatry 85 (6), 668-674, 2014 | 165 | 2014 |
| Withdrawing amantadine in dyskinetic patients with Parkinson disease The AMANDYSK trial F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ... Neurology 82 (4), 300-307, 2014 | 161 | 2014 |
| Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3) W Oertel, K Eggert, R Pahwa, CM Tanner, RA Hauser, C Trenkwalder, ... Movement Disorders 32 (12), 1701-1709, 2017 | 157 | 2017 |
| A prospective single-blind study of Gamma Knife thalamotomy for tremor T Witjas, R Carron, P Krack, A Eusebio, M Vaugoyeau, M Hariz, JP Azulay, ... Neurology, 10.1212/WNL. 0000000000002087, 2015 | 148 | 2015 |
| Dopaminergic modulation of the default mode network in Parkinson's disease P Delaveau, P Salgado-Pineda, P Fossati, T Witjas, JP Azulay, O Blin European Neuropsychopharmacology 20 (11), 784-792, 2010 | 147 | 2010 |
| Increased visual dependence in Parkinson's disease JP Azulay, S Mesure, B Amblard, J Pouget Perceptual and Motor Skills 95 (3_suppl), 1106-1114, 2002 | 147 | 2002 |
